Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002055011-25-000004
Filing Date
2025-02-05
Accepted
2025-02-05 16:02:10
Documents
3
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1738789319.html 3  
1 FORM 3 wk-form3_1738789319.xml 3 12297
2 EX-24 imampoa.htm EX-24 4173
3 imampoa001.jpg GRAPHIC 215733
  Complete submission text file 0002055011-25-000004.txt   315403
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Issuer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 ALLEN ROAD 2ND FLOOR BASKING RIDGE NJ 07920
Business Address
Imam Tariq (Reporting) CIK: 0002055011 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33650 | Film No.: 25593158